MSMarwa Saleh

Marwa Saleh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marwa Saleh has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Urinary Vitamin D Binding Protein Level in Egyptian Systemic Lupus Erythematosus Patients: A Potential Biomarker for Lupus Nephritis and its Association with Renal Activity

    by Elshahat A. Yousef, Eman Nagy, Omnia M. El Sayed Mohamed, Mohamed S. Elghonimy, Marwa Saleh

    Background : Systemic Lupus Erythematosus (SLE) is an autoimmune inflammatory disease affecting various organs, notably the kidneys, leading to lupus Nephritis (LN) in approximately half of patients. Early and accurate diagnosis of lupus nephritis (LN) and initiation of therapy are crucial steps in halting disease progression. Despite its value as a gold standard for diagnosing, classifying, and guiding treatment for LN patients, renal biopsy is expensive, carries risks, and cannot expect the response to immunosuppressive therapy. Methods : The study included 80 SLE patients; 60 patients were biopsy-proven LN (30 patients with active LN, and 30 patients with LN in remission), and 20 without LN. After complete history taking and clinical examination, laboratory investigations were done including measurement of urinary VDBP. The SLE disease activity, and renal disease activity were assessed using SLEDAI and renal SLEDAI score respectively. Results : Urinary VDBP was significantly higher in LN group with median 3.33(2.67- 4.53) μg/ml when compared to SLE group without LN with median 2.35(1.40-3.22) μg/ml. However, there were no statistically significant differences in urinary VDBP level between active and remission LN groups, although it was, to some extent, higher in active LN group with median 3.58(2.73-4.83) μg/ml and 3.23(1.94-4.25) μg/ml in remission group. Urinary VDBP at cut-off value of 2.12 showed 100% sensitivity and 50% specificity in identifying cases with active LN. Conclusion : Higher urinary VDBP levels may be a potential marker for newly developed LN among SLE patients.

  • Open Access

    Clinical and Ultrasonographic Characteristics of the Achilles Tendon in Hemodialysis Patients

    by Samar Tharwat, Marwa Saleh, Rabab Elrefaey, Mona Kamal Nassar, Mohammed Kamal Nassar

    Background and Objectives: The early recognition of tendon alterations in chronic hemodialysis (HD) patients, an awareness of the factors that influence the condition, and active intervention have considerable clinical relevance. The aim of this study was to investigate the musculoskeletal ultrasound (MSUS) features of the Achilles tendon in chronic HD patients and determine the factors associated with tendon abnormalities. Materials and Methods: This study was conducted on 46 HD patients and 24 sex- and age-matched controls. All participants were evaluated clinically for any signs of Achilles tendon abnormalities. Then, the Achilles tendon was scanned bilaterally using MSUS. Results: Among the 92 Achilles tendons in the HD patients, there was tenderness and swelling of only two (2.2%). Regarding MSUS features, there were statistically significant higher thicknesses in the proximal end (p < 0.001), midpoint (p < 0.001), and distal end (p < 0.001) of the Achilles tendons in the HD patients when compared with the healthy controls. Tendinosis was found in 12 (13%) of the HD patients’ Achilles tendons, which was statistically significant in comparison to the healthy controls (p = 0.008). There were statistically significant higher scores of structural abnormalities (p = 0.005), bone erosions (p = 0.017), and calcifications (p = 0.015) in the HD patients when compared to the healthy controls. According to the results of a univariate regression analysis, age and male gender were predictive for US abnormalities in HD patients (p = 0.002 and 0.025, respectively). Conclusions: The Achilles tendon in subjects on chronic HD showed frequent US abnormalities. These abnormalities in HD patients appear to be more related to age and gender and may be asymptomatic.


  • Open Access

    Clinical features, radiological characteristics, and outcome of coronavirus disease-2019 (COVID-19) infection among hospitalized patients with autoimmune and rheumatic diseases: A multicenter study

    by Samar Tharwat, Gehad A. Saleh, Haidy Ali Mohammed, Mohammed Kamal Nassar, Marwa Saleh, Esraa Jamal, Shaimaa El-Ashwah

  • Open Access

    Chest CT Total Severity Score on Admission to Predict In-Hospital Mortality in COVID-19 Patients with Acute and Chronic Renal Impairment

    by Samar Tharwat, Gehad A. Saleh, Marwa Saleh, Ahmad M. Mounir, Dina G. Abdelzaher, Ahmed M Salah, Mohammed Kamal Nassar

    Aim: To identify the predictors of in-hospital mortality in patients with coronavirus disease of 2019 (COVID-19) and acute renal impairment (ARI) or chronic kidney disease (CKD), and to evaluate the performance and inter-reader concordance of chest CT total severity scores (TSSs). Methods: This retrospective single-center study was conducted on symptomatic COVID-19 patients with renal impairment (either acute or chronic) and a serum creatinine of >2 mg/dL at the time of admission. The patients’ demographic characteristics, clinical data, and laboratory data were extracted from the clinical computerized medical records. All chest CT images obtained at the time of hospital admission were analyzed. Two radiologists independently assessed the pulmonary abnormalities and scored the severity using CT chest total severity score (TSS). Univariate logistic regression analysis was used to determine factors associated with in-hospital mortality. A receiver operating characteristic (ROC) curve analysis was performed for the TSS in order to identify the cut-off point that predicts mortality. Bland–Altman plots were used to evaluate agreement between the two radiologists assessing TSS. Results: A total of 100 patients were included, with a mean age of 60 years, 54 were males, 53 had ARI, and 47 had CKD. In terms of in-hospital mortality, 60 patients were classified in the non-survivor group and 40 were classified in the survivor group. The mortality rate was higher for those with ARI compared to those with CKD (p = 0.033). The univariate regression analysis showed an increasing odds of in-hospital mortality associated with higher respiratory rate (OR 1.149, 95% CI 1.057–1.248, p = 0.001), total bilirubin (OR 2.532, 95% CI 1.099–5.836, p = 0.029), lactate dehydrogenase (LDH) (OR 1.001, 95% CI 1.000–1.003, p = 0.018), CRP (OR 1.010, 95% CI 1.002–1.017, p = 0.012), invasive mechanical ventilation (MV) (OR 7.667, 95% CI 2.118–27.755, p = 0.002), a predominant pattern of pulmonary consolidation (OR 21.714, 95% CI 4.799–98.261, p < 0.001), and high TSS (OR 2.082, 95% CI 1.579–2.745, p < 0.001). The optimum cut-off value of TSS used to predict in-hospital mortality was 8.5 with a sensitivity of 86.7% and a specificity of 87.5%. There was excellent interobserver agreement (ICC > 0.9) between the two independent radiologists in their quantitative assessment of pulmonary changes using TSS. Conclusions: In-hospital mortality is high in COVID-19 patients with ARI/CKD, especially for those with ARI. High serum bilirubin, a predominant pattern of pulmonary consolidation, and TSS are the most significant predictors of mortality in these patients. Patients with a higher TSS may require more intensive hospital care. TSS is a reliable and helpful auxiliary tool for risk stratification among COVID-19 patients with ARI/CKD.